Image may be NSFW.
Clik here to view.
Durvalumab combined with chemotherapy improve overall survival in patients with late-stage small cell lung cancer, according to research presented at the 2019 World Conference hosted by the International Association for the Study of Lung Cancer (IASLC).
The research was presented by Dr. Luis Paz-Ares, from Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, in Madrid, Spain.
Extensive-stage small-cell lung cancer is defined as the stage during ...
Clik here to view.
Durvalumab combined with chemotherapy improve overall survival in patients with late-stage small cell lung cancer, according to research presented at the 2019 World Conference hosted by the International Association for the Study of Lung Cancer (IASLC).
The research was presented by Dr. Luis Paz-Ares, from Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, in Madrid, Spain.
Extensive-stage small-cell lung cancer is defined as the stage during ...
